PIPELINE

Pipeline

Pipeline table
Pipeline Target Indication Discovery Pre-clinical Phase 1 Phase 2 Phase 3
MFC0101 Glioblastoma
35%
Brain Metastases
35%
MFC0102 Solid tumor
14.5%
NASH
14.5%
Anti-viral
14.5%
MFC0201 Glioblastoma
14.5%
MFC0202 Leukemia
9.5%
MFC0301 Glioblastoma
9.5%
MFB0102 Solid tumor / Blood cancer
14.5%
MFB0202 Solid tumor / Blood cancer
14.5%